EUVIMEDEUVIMED entdecken
Open Access

Anticancer effects of the HDAC inhibitor, 3β,6β‑dihydroxyurs‑12‑en‑27‑oic acid, in MCF‑7 breast cancer cells via the inhibition of Akt/mTOR pathways

Jong Seung Lim, So Young Kyung, Yukyoung Jeon, In Su Kim, Jong Hwan Kwak, Hyung Sik Kim

Oncology Reports · 2023

DOI: 10.3892/or.2023.8480 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Reports, 2023. Verfasst von Jong Seung Lim und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Sungkyunkwan University, Suwon, Gyeonggi-do 16419, Republic of Korea. Hauptthemen laut MEDLINE: Breast Neoplasms, Histone Deacetylase Inhibitors, Antineoplastic Agents, Saxifragaceae. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsHistone Deacetylase InhibitorsAntineoplastic AgentsSaxifragaceaeFemaleHumansApoptosisCell Line, TumorCell ProliferationMCF-7 CellsProto-Oncogene Proteins c-aktProto-Oncogene Proteins c-bcl-2TOR Serine-Threonine KinasesVorinostat

Stichwörter der Autor:innen

3β6β‑dihydroxyurs‑12‑en‑27‑oic acidAstilbe chinensisHDAC inhibitorapoptosisautophagybreast cancercell cycle

Substanzen

Histone Deacetylase InhibitorsMTOR protein, humanProto-Oncogene Proteins c-aktProto-Oncogene Proteins c-bcl-2TOR Serine-Threonine KinasesVorinostatAntineoplastic Agents

Autor:innen und Institutionen

  • School of Pharmacy, Sungkyunkwan University, Suwon, Gyeonggi-do 16419, Republic of Korea.

Zitieren

APA

Lim, J. S., Kyung, S. Y., Jeon, Y., Kim, I. S., Kwak, J. H., & Kim, H. S. (2023). Anticancer effects of the HDAC inhibitor, 3β,6β‑dihydroxyurs‑12‑en‑27‑oic acid, in MCF‑7 breast cancer cells via the inhibition of Akt/mTOR pathways. Oncology Reports. https://doi.org/10.3892/or.2023.8480

Vancouver

Lim JS, Kyung SY, Jeon Y, Kim IS, Kwak JH, Kim HS. Anticancer effects of the HDAC inhibitor, 3β,6β‑dihydroxyurs‑12‑en‑27‑oic acid, in MCF‑7 breast cancer cells via the inhibition of Akt/mTOR pathways. Oncology Reports. 2023. doi:10.3892/or.2023.8480

BibTeX
@article{Lim2023,
  author = {Lim, Jong Seung and Kyung, So Young and Jeon, Yukyoung and Kim, In Su and Kwak, Jong Hwan and Kim, Hyung Sik},
  title = {Anticancer effects of the HDAC inhibitor, 3β,6β‑dihydroxyurs‑12‑en‑27‑oic acid, in MCF‑7 breast cancer cells via the inhibition of Akt/mTOR pathways},
  journal = {Oncology Reports},
  year = {2023},
  doi = {10.3892/or.2023.8480}
}
Kostenlos starten →